CDW Invest BVBA – represented by Christiaan De Wilde
Director
Christiaan De Wilde holds a degree in accountancy from BME Gent, a degree in taxation from EHSAL Brussels, and a masters degree in industrial entrepreneurship from EHSAL Brussels. Mr De Wilde joined Johnson & Johnson in October 1988, where he provided excellent leadership, both financially and strategically, to the many businesses he partnered over his 17-year career. From June 2000 until May 2005, Christiaan De Wilde was Finance & Logistics Director Benelux and member of the Board of Johnson & Johnson Medical BV. Until August 2006, he was Finance & Logistics Director and member of the Board of Janssen-Cilag Belgium NV. In this capacity Mr De Wilde was instrumental in providing financial leadership to the Janssen-Cilag organization and had overall responsibility for all Finance and Logistic processes. Christiaan De Wilde was appointed Chief Financial & Administration Officer of Innogenetics on September 1, 2006 and became Chief Executive Officer and a member of the Board of the Company on October 12, 2007.